Multi‐cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.
Ali M, Timsina J, Shen Y, Do A, Wang L, Western D, Liu E, Beric A, Heo G, Budde JP, Gentsch J, Schindler SE, Morris JC, Holtzman DM, Ruiz A, Alvarez I, Aguilar M, Pastor P, Rutledge J, Oh H, Wilson EN, Guen YL, Khalid RR; Alzheimer's Disease Neuroimaging Initiative (ADNI); Knight Alzheimer Disease Research Center (Knight ADRC); Fundació ACE Alzheimer Center Barcelona (FACE); Stanford Alzheimer Disease Research Center (Stanford ADRC); Robins C, Pulford DJ, Ibanez L, Wyss‐Coray T, Sung YJ, Cruchaga C.
Ali M, et al. Among authors: liu e.
Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e084185. doi: 10.1002/alz.084185. eCollection 2024 Dec.
Alzheimers Dement. 2025.
PMID: 39786171
Free PMC article.